We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

KGH:GPWKGHM Polska Miedz S.A. Analysis

Data as of 2026-07-13 - not real-time

PLN 306.65

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

KGHM is trading at ~PLN 306.6, comfortably above the calculated support of ~PLN 297.7 and below the 20‑day SMA of ~PLN 336, with the 50‑day SMA still higher, indicating a neutral short‑term trend. The RSI sits near 39, suggesting modest oversold pressure, while the MACD line remains below its signal, delivering a bearish histogram. Valuation metrics show a trailing PE of ~9x and a DCF‑derived fair value of ~PLN 385, implying a modest (~2%) upside and an overall undervalued stance. The company posted a 33% revenue surge YoY, robust operating (34%) and profit (18%) margins, and record‑high Q1 EBITDA, underscoring strong earnings momentum.
However, free cash flow is negative and debt‑to‑equity is high, raising concerns about cash generation and leverage. The beta of ~0.57 signals low market sensitivity, yet 30‑day volatility exceeds 58%, and the Fear & Greed Index is in “Extreme Greed,” hinting at potential market complacency. Dividend yield is modest at 0.5% with a zero payout ratio, questioning sustainability. Overall, the stock presents a blend of value and growth attributes, with short‑term technical softness offset by solid fundamentals and a slight valuation edge.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • RSI near oversold levels (~39)
  • Price close to support zone (~PLN 298)
  • Bearish MACD histogram

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong revenue growth (≈33% YoY) and expanding margins
  • DCF fair value above current price indicating upside
  • Record Q1 EBITDA and favorable copper price environment

Long Term

> 3 years
Neutral
Model confidence: 7/10

Key Factors

  • Long‑term copper demand driven by energy transition
  • Diversified global asset base reducing single‑country exposure
  • High leverage (debt‑to‑equity ~17) and negative free cash flow

Key Metrics & Analysis

Financial Health

Revenue Growth32.80%
Profit Margin17.53%
P/E Ratio8.9
ROE20.13%
ROA7.51%
Debt/Equity16.96
P/B Ratio1.7
Op. Cash FlowPLN3.3B
Free Cash FlowPLN-1950875008

Technical Analysis

TrendNeutral
RSI39.5
SupportPLN 297.70
ResistancePLN 396.40
MA 20PLN 336.43
MA 50PLN 339.74
MA 200PLN 279.15
MACDBearish
VolumeDecreasing
Fear & Greed Index92.63

Valuation

Fair ValuePLN 385.45
Target PricePLN 313.28
Upside/Downside2.16%
GradeUndervalued
TypeBlend
Dividend Yield0.49%

Risk Assessment

Beta0.57
Volatility58.89%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.